359 related articles for article (PubMed ID: 21708003)
1. "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial.
Ten Hoedt AE; Hollak CE; Boelen CC; van der Herberg-van de Wetering NA; Ter Horst NM; Jonkers CF; Wijburg FA; Bosch AM
Orphanet J Rare Dis; 2011 Jun; 6():48. PubMed ID: 21708003
[TBL] [Abstract][Full Text] [Related]
2. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
[TBL] [Abstract][Full Text] [Related]
3. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
[TBL] [Abstract][Full Text] [Related]
4. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
[TBL] [Abstract][Full Text] [Related]
5. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
[TBL] [Abstract][Full Text] [Related]
6. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics for improved treatment monitoring of phenylketonuria: urinary biomarkers for non-invasive assessment of dietary adherence and nutritional deficiencies.
Wild J; Shanmuganathan M; Hayashi M; Potter M; Britz-McKibbin P
Analyst; 2019 Nov; 144(22):6595-6608. PubMed ID: 31608347
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Control of Patients with Phenylketonuria in a Portuguese Metabolic Centre Comparing Three Different Recommendations.
Kanufre V; Almeida MF; Barbosa CS; Carmona C; Bandeira A; Martins E; Rocha S; Guimas A; Ribeiro R; MacDonald A; Pinto A; Rocha JC
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578995
[TBL] [Abstract][Full Text] [Related]
9. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
10. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
11. Large Neutral Amino Acid Therapy Increases Tyrosine Levels in Adult Patients with Phenylketonuria: A Long-Term Study.
Burlina AP; Cazzorla C; Massa P; Polo G; Loro C; Gueraldi D; Burlina AB
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31640267
[TBL] [Abstract][Full Text] [Related]
12. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study.
Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J
Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949
[TBL] [Abstract][Full Text] [Related]
13. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
[TBL] [Abstract][Full Text] [Related]
14. Response to sapropterin hydrochloride (Kuvan®) in children with phenylketonuria (PKU): a clinical trial.
Eshraghi P; Noroozi Asl S; Bagheri S; Chalak V
J Pediatr Endocrinol Metab; 2019 Aug; 32(8):885-888. PubMed ID: 31237861
[TBL] [Abstract][Full Text] [Related]
15. Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients.
Teruya KI; Remor E; Schwartz IVD
Am J Med Genet A; 2021 Jul; 185(7):1991-2002. PubMed ID: 33765361
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
[TBL] [Abstract][Full Text] [Related]
17. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
18. Cognition after a 4-week high phenylalanine intake in adults with phenylketonuria - a randomized controlled trial.
Trepp R; Muri R; Maissen-Abgottspon S; Haynes AG; Hochuli M; Everts R
Am J Clin Nutr; 2024 Apr; 119(4):908-916. PubMed ID: 38569786
[TBL] [Abstract][Full Text] [Related]
19. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry.
Kenneson A; Singh RH
Mol Genet Metab; 2021 Nov; 134(3):243-249. PubMed ID: 34654619
[TBL] [Abstract][Full Text] [Related]
20. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency.
Nardecchia F; Chiarotti F; Carducci C; Santagata S; Valentini G; Angeloni A; Blau N; Leuzzi V
Eur J Pediatr; 2017 Jul; 176(7):917-924. PubMed ID: 28540433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
